GERUSSI ALESSIO

Gerussi, A., Cappadona, C., Bernasconi, D., Cristoferi, L., Valsecchi, M., Carbone, M., et al. (2024). Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score. LIVER INTERNATIONAL, 44(8 (August 2024)), 1952-1960 [10.1111/liv.15916]. Detail

Cordell, H., Fryett, J., Ueno, K., Darlay, R., Aiba, Y., Hitomi, Y., et al. (2023). Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] [Altro] [10.1016/j.jhep.2022.12.001]. Detail

Murillo Perez, C., Gerussi, A., Trivedi, P., Corpechot, C., Van Der Meer, A., Maria Battezzati, P., et al. (2023). Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 35(1), 112-119 [10.1097/MEG.0000000000002464]. Detail

Cristoferi, L., Porta, M., Bernasconi, D., Leonardi, F., Gerussi, A., Mulinacci, G., et al. (2023). A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. DIGESTIVE AND LIVER DISEASE, 55(3 (March 2023)), 373-380 [10.1016/j.dld.2022.10.015]. Detail

Mulinacci, G., Cristoferi, L., Palermo, A., Lucà, M., Gerussi, A., Invernizzi, P., et al. (2023). Risk stratification in primary sclerosing cholangitis. MINERVA GASTROENTEROLOGY, 69(1), 84-94 [10.23736/S2724-5985.20.02821-4]. Detail